These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18727054)

  • 1. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
    Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
    Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte tissue factor levels in cancer patients.
    Lwaleed BA; Francis JL; Chisholm M
    Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M; Abdelaziz A; Abbas A; Mahmoud K; Fathy H; El Mongy S; El-Basyuoni S; Ahmed H; McCoy P
    Nephrol Dial Transplant; 2009 May; 24(5):1495-9. PubMed ID: 19039027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
    Brunner M; Thurnher D; Heiduschka G; Grasl MCh; Brostjan C; Erovic BM
    J Surg Oncol; 2008 Dec; 98(7):545-50. PubMed ID: 18792958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
    Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
    Del Papa N; Colombo G; Fracchiolla N; Moronetti LM; Ingegnoli F; Maglione W; Comina DP; Vitali C; Fantini F; Cortelezzi A
    Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach for rapid and reliable enumeration of circulating endothelial cells in patients.
    Kraan J; Strijbos MH; Sieuwerts AM; Foekens JA; den Bakker MA; Verhoef C; Sleijfer S; Gratama JW
    J Thromb Haemost; 2012 May; 10(5):931-9. PubMed ID: 22385979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.
    Boos CJ; Balakrishnan B; Blann AD; Lip GY
    J Thromb Haemost; 2008 Nov; 6(11):1841-50. PubMed ID: 18761720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
    Davidson B; Dong HP; Holth A; Berner A; Risberg B
    Breast J; 2008; 14(5):476-82. PubMed ID: 18657145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay.
    Jacques N; Vimond N; Conforti R; Griscelli F; Lecluse Y; Laplanche A; Malka D; Vielh P; Farace F
    J Immunol Methods; 2008 Sep; 337(2):132-43. PubMed ID: 18662694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endothelial cells and endothelial activation in essential thrombocythemia: results from CD146+ immunomagnetic enrichment--flow cytometry and soluble E-selectin detection.
    Belotti A; Elli E; Speranza T; Lanzi E; Pioltelli P; Pogliani E
    Am J Hematol; 2012 Mar; 87(3):319-20. PubMed ID: 22190201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer.
    Garcia JA; Rosenberg JE; Weinberg V; Scott J; Frohlich M; Park JW; Small EJ
    BJU Int; 2007 Mar; 99(3):519-24. PubMed ID: 17407512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry.
    Simpson SJ; Vachula M; Kennedy MJ; Kaizer H; Coon JS; Ghalie R; Williams S; Van Epps D
    Exp Hematol; 1995 Sep; 23(10):1062-8. PubMed ID: 7544737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating endothelial cells in cancer patients do not express tissue factor.
    Beerepoot LV; Mehra N; Linschoten F; Jorna AS; Lisman T; Verheul HM; Voest EE
    Cancer Lett; 2004 Sep; 213(2):241-8. PubMed ID: 15327840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelial cells: a novel marker of endothelial damage.
    Erdbruegger U; Haubitz M; Woywodt A
    Clin Chim Acta; 2006 Nov; 373(1-2):17-26. PubMed ID: 16836991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.
    Goon PK; Boos CJ; Stonelake PS; Blann AD; Lip GY
    Thromb Haemost; 2006 Jul; 96(1):45-52. PubMed ID: 16807650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
    Bauernhofer T; Zenahlik S; Hofmann G; Balic M; Resel M; Pirchmoser R; Regitnig P; Ambros P; Dandachi N; Samonigg H
    Oncol Rep; 2005 Feb; 13(2):179-84. PubMed ID: 15643496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
    Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
    Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.